Pfizer Inc (PFIZ34) — Capital Reinvestment Ratio
Pfizer Inc (PFIZ34) has a Capital Reinvestment Ratio of 0.17x as of March 2026, meaning it reinvests 0% of its operating cash flow (R$2.62 Billion) in capital expenditures (R$436.00 Million). See net asset quality index of Pfizer Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pfizer Inc Capital Reinvestment Ratio (2014–2025)
This chart tracks Pfizer Inc's Capital Reinvestment Ratio across 12 annual periods. Check Pfizer Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Pfizer Inc (2014–2025)
Year-by-year Capital Reinvestment Ratio for Pfizer Inc from 2014 to 2025. For live market cap and broader valuation context, see how much is Pfizer Inc worth.
| Year | Reinvestment Ratio | Operating CF (BRL) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | R$11.71 Billion | R$2.63 Billion | ▼ -1.6% |
| 2024 | 0.23x | R$12.74 Billion | R$2.91 Billion | ▼ -28.9% |
| 2023 | 0.32x | R$12.04 Billion | R$3.86 Billion | ▲ +190.2% |
| 2022 | 0.11x | R$29.27 Billion | R$3.24 Billion | ▲ +32.9% |
| 2021 | 0.08x | R$32.58 Billion | R$2.71 Billion | ▼ -57.1% |
| 2020 | 0.19x | R$14.40 Billion | R$2.79 Billion | ▼ -6.0% |
| 2019 | 0.21x | R$12.59 Billion | R$2.59 Billion | ▲ +48.5% |
| 2018 | 0.14x | R$15.83 Billion | R$2.20 Billion | ▲ +5.2% |
| 2017 | 0.13x | R$16.80 Billion | R$2.22 Billion | ▲ +6.9% |
| 2016 | 0.12x | R$16.19 Billion | R$2.00 Billion | ▲ +29.8% |
| 2015 | 0.10x | R$14.69 Billion | R$1.40 Billion | ▲ +35.5% |
| 2014 | 0.07x | R$17.08 Billion | R$1.20 Billion | — |